Voyager Therapeutics, Inc.

VYGR

—

Advanced chart & tools →

Voyager Therapeutics, Inc.VYGR

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-2.04

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$40.37M

Net income

$-119.72M

Net margin

-296.5%

Gross margin

—

Dividends & financials

Voyager Therapeutics, Inc. (VYGR) reported revenue of $40.37M and net income of $-119.72M, or $-2.04 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.